Skip to main content
Top
Published in: Inflammation 3/2020

01-06-2020 | Original Article

Proanthocyanidins Promote Osteogenic Differentiation of Human Periodontal Ligament Fibroblasts in Inflammatory Environment Via Suppressing NF-κB Signal Pathway

Authors: Jiahui Huang, Lianlian Liu, Shanshan Jin, Yu Zhang, Liguo Zhang, Shutong Li, Aimei Song, Pishan Yang

Published in: Inflammation | Issue 3/2020

Login to get access

Abstract

Proanthocyanidins (PA) have been proven to suppress inflammation and promote osteogenic differentiation. However, whether PA could promote osteogenic differentiation of human periodontal ligament fibroblasts (HPDLFs) in inflammatory environment is unclear. Here, HPDLFs were stimulated by tumor necrosis factor-α (TNF-α), PA, or their combination, and osteogenic differentiation- and mineralization-associated markers were detected by quantitative real-time polymerase chain reaction (qRT-PCR), alizarin red S staining, and alkaline phosphatase (ALP) activity assay. The result showed that PA significantly upregulated expression of osteogenesis-related genes and proteins and ALP activity in HPDLFs compared with the control in non-inflammatory environment. Moreover, PA significantly reversed inhibition of osteogenesis-related gene and protein expression, ALP activity, and mineralization caused by TNF-α. The underlying mechanism was that PA could regulate osteogenesis of HPDLFs via suppressing nuclear factor-kappa beta (NF-κB) signal pathway. These findings suggest that PA may contribute to bone generation in inflammatory microenvironment via suppressing NF-κB signal pathway. Thus, PA may be a potential treatment agent for periodontal bone regeneration.
Literature
1.
go back to reference Pihlstrom, B.L., B.S. Michalowicz, and N.W. Johnson. 2005. Periodontal diseases. Lancet 366 (9499): 1809–1820.CrossRef Pihlstrom, B.L., B.S. Michalowicz, and N.W. Johnson. 2005. Periodontal diseases. Lancet 366 (9499): 1809–1820.CrossRef
2.
go back to reference Gokhale, S.R., and A.M. Padhye. 2013. Future prospects of systemic host modulatory agents in periodontal therapy. British Dental Journal 214 (9): 467–471.CrossRef Gokhale, S.R., and A.M. Padhye. 2013. Future prospects of systemic host modulatory agents in periodontal therapy. British Dental Journal 214 (9): 467–471.CrossRef
3.
go back to reference Chou, A.M., V. Sae-Lim, T.M. Lim, J.T. Schantz, S.H. Teoh, C.L. Chew, and D.W. Hutmacher. 2002. Culturing and characterization of human periodontal ligament fibroblasts - a preliminary study. Materials Science & Engineering C-Biomimetic and Supramolecular Systems 20 (1–2): 77–83.CrossRef Chou, A.M., V. Sae-Lim, T.M. Lim, J.T. Schantz, S.H. Teoh, C.L. Chew, and D.W. Hutmacher. 2002. Culturing and characterization of human periodontal ligament fibroblasts - a preliminary study. Materials Science & Engineering C-Biomimetic and Supramolecular Systems 20 (1–2): 77–83.CrossRef
4.
go back to reference Inanc, B., A.E. Elcin, and Y.M. Elcin. 2006. Osteogenic induction of human periodontal ligament fibroblasts under two- and three-dimensional culture conditions. Tissue Engineering 12 (2): 257–266.CrossRef Inanc, B., A.E. Elcin, and Y.M. Elcin. 2006. Osteogenic induction of human periodontal ligament fibroblasts under two- and three-dimensional culture conditions. Tissue Engineering 12 (2): 257–266.CrossRef
5.
go back to reference Nagatomo, K., M. Komaki, I. Sekiya, Y. Sakaguchi, K. Noguchi, S. Oda, T. Muneta, and I. Ishikawa. 2006. Stem cell properties of human periodontal ligament cells. Journal of Periodontal Research 41 (4): 303–310.CrossRef Nagatomo, K., M. Komaki, I. Sekiya, Y. Sakaguchi, K. Noguchi, S. Oda, T. Muneta, and I. Ishikawa. 2006. Stem cell properties of human periodontal ligament cells. Journal of Periodontal Research 41 (4): 303–310.CrossRef
6.
go back to reference Yang, N., Y. Li, G. Wang, Y. Ding, Y. Jin, and Y.Q. Xu. 2017. Tumor necrosis factor-alpha suppresses adipogenic and osteogenic differentiation of human periodontal ligament stem cell by inhibiting miR-21/Spry1 functional axis. Differentiation 97: 33–43.CrossRef Yang, N., Y. Li, G. Wang, Y. Ding, Y. Jin, and Y.Q. Xu. 2017. Tumor necrosis factor-alpha suppresses adipogenic and osteogenic differentiation of human periodontal ligament stem cell by inhibiting miR-21/Spry1 functional axis. Differentiation 97: 33–43.CrossRef
7.
go back to reference Nishikawa, M., Y. Yamaguchi, K. Yoshitake, and Y. Saeki. 2002. Effects of TNFalpha and prostaglandin E2 on the expression of MMPs in human periodontal ligament fibroblasts. Journal of Periodontal Research 37 (3): 167–176.CrossRef Nishikawa, M., Y. Yamaguchi, K. Yoshitake, and Y. Saeki. 2002. Effects of TNFalpha and prostaglandin E2 on the expression of MMPs in human periodontal ligament fibroblasts. Journal of Periodontal Research 37 (3): 167–176.CrossRef
8.
go back to reference Kitaura, H., K. Kimura, M. Ishida, H. Kohara, M. Yoshimatsu, and T. Takano-Yamamoto. 2013. Immunological reaction in TNF-alpha-mediated osteoclast formation and bone resorption in vitro and in vivo. Clinical & Developmental Immunology. Kitaura, H., K. Kimura, M. Ishida, H. Kohara, M. Yoshimatsu, and T. Takano-Yamamoto. 2013. Immunological reaction in TNF-alpha-mediated osteoclast formation and bone resorption in vitro and in vivo. Clinical & Developmental Immunology.
9.
go back to reference Zhao, B. 2017. TNF and bone remodeling. Current Osteoporosis Reports 15 (3): 126–134.CrossRef Zhao, B. 2017. TNF and bone remodeling. Current Osteoporosis Reports 15 (3): 126–134.CrossRef
10.
go back to reference Lacey, D.C., P.J. Simmons, S.E. Graves, and J.A. Hamilton. 2009. Proinflammatory cytokines inhibit osteogenic differentiation from stem cells: implications for bone repair during inflammation. Osteoarthritis and Cartilage 17 (6): 735–742.CrossRef Lacey, D.C., P.J. Simmons, S.E. Graves, and J.A. Hamilton. 2009. Proinflammatory cytokines inhibit osteogenic differentiation from stem cells: implications for bone repair during inflammation. Osteoarthritis and Cartilage 17 (6): 735–742.CrossRef
11.
go back to reference Panagakos, F.S., L.P. Hinojosa, and S. Kumar. 1994. Formation and mineralization of extracellular matrix secreted by an immortal human osteoblastic cell line: modulation by tumor necrosis factor-alpha. Inflammation 18 (3): 267–284.CrossRef Panagakos, F.S., L.P. Hinojosa, and S. Kumar. 1994. Formation and mineralization of extracellular matrix secreted by an immortal human osteoblastic cell line: modulation by tumor necrosis factor-alpha. Inflammation 18 (3): 267–284.CrossRef
12.
go back to reference Kolarz, B., B. Targonska-Stepniak, D. Darmochwal-Kolarz, and M. Majdan. 2007. Autoimmune aspects of treatment with TNF-alpha inhibitors. Postȩpy Higieny i Medycyny Doświadczalnej (Online) 61: 478–484. Kolarz, B., B. Targonska-Stepniak, D. Darmochwal-Kolarz, and M. Majdan. 2007. Autoimmune aspects of treatment with TNF-alpha inhibitors. Postȩpy Higieny i Medycyny Doświadczalnej (Online) 61: 478–484.
13.
go back to reference Tang, W., Y. Lu, Q.Y. Tian, Y. Zhang, F.J. Guo, G.Y. Liu, N.M. Syed, Y. Lai, E.A. Lin, L. Kong, J. Su, F. Yin, A.H. Ding, A. Zanin-Zhorov, M.L. Dustin, J. Tao, J. Craft, Z. Yin, J.Q. Feng, S.B. Abramson, X.P. Yu, and C.J. Liu. 2011. The growth factor progranulin binds to TNF receptors and is therapeutic against inflammatory arthritis in mice. Science 332 (6028): 478–484.CrossRef Tang, W., Y. Lu, Q.Y. Tian, Y. Zhang, F.J. Guo, G.Y. Liu, N.M. Syed, Y. Lai, E.A. Lin, L. Kong, J. Su, F. Yin, A.H. Ding, A. Zanin-Zhorov, M.L. Dustin, J. Tao, J. Craft, Z. Yin, J.Q. Feng, S.B. Abramson, X.P. Yu, and C.J. Liu. 2011. The growth factor progranulin binds to TNF receptors and is therapeutic against inflammatory arthritis in mice. Science 332 (6028): 478–484.CrossRef
14.
go back to reference Wei, F.H., Y.Y. Zhang, W.M. Zhao, X.P. Yu, and C.J. Liu. 2014. Progranulin facilitates conversion and function of regulatory T cells under inflammatory conditions. PLoS One 9 (11). Wei, F.H., Y.Y. Zhang, W.M. Zhao, X.P. Yu, and C.J. Liu. 2014. Progranulin facilitates conversion and function of regulatory T cells under inflammatory conditions. PLoS One 9 (11).
15.
go back to reference Ma, Z.R., X.P. Liu, X.S. Xu, J. Jiang, J. Zhou, J. Wang, D.W. Chen, and S. Luo. 2017. Safety of tumor necrosis factor-alpha inhibitors for treatment of ankylosing spondylitis: a meta-analysis. Medicine 96 (25). Ma, Z.R., X.P. Liu, X.S. Xu, J. Jiang, J. Zhou, J. Wang, D.W. Chen, and S. Luo. 2017. Safety of tumor necrosis factor-alpha inhibitors for treatment of ankylosing spondylitis: a meta-analysis. Medicine 96 (25).
16.
go back to reference Chu, H., Q. Tang, H. Huang, W. Hao, and X. Wei. 2016. Grape-seed proanthocyanidins inhibit the lipopolysaccharide-induced inflammatory mediator expression in RAW264.7 macrophages by suppressing MAPK and NF-kappab signal pathways. Environmental Toxicology and Pharmacology 41: 159–166.CrossRef Chu, H., Q. Tang, H. Huang, W. Hao, and X. Wei. 2016. Grape-seed proanthocyanidins inhibit the lipopolysaccharide-induced inflammatory mediator expression in RAW264.7 macrophages by suppressing MAPK and NF-kappab signal pathways. Environmental Toxicology and Pharmacology 41: 159–166.CrossRef
17.
go back to reference Park, J.S., M.K. Park, H.J. Oh, Y.J. Woo, M.A. Lim, J.H. Lee, J.H. Ju, et al. 2012. Grape-seed proanthocyanidin extract as suppressors of bone destruction in inflammatory autoimmune arthritis. PLoS One 7 (12). Park, J.S., M.K. Park, H.J. Oh, Y.J. Woo, M.A. Lim, J.H. Lee, J.H. Ju, et al. 2012. Grape-seed proanthocyanidin extract as suppressors of bone destruction in inflammatory autoimmune arthritis. PLoS One 7 (12).
18.
go back to reference Rasmussen, S.E., H. Frederiksen, K. Struntze Krogholm, and L. Poulsen. 2005. Dietary proanthocyanidins: occurrence, dietary intake, bioavailability, and protection against cardiovascular disease. Molecular Nutrition & Food Research 49 (2): 159–174.CrossRef Rasmussen, S.E., H. Frederiksen, K. Struntze Krogholm, and L. Poulsen. 2005. Dietary proanthocyanidins: occurrence, dietary intake, bioavailability, and protection against cardiovascular disease. Molecular Nutrition & Food Research 49 (2): 159–174.CrossRef
19.
go back to reference Wang, W., L. Zhan, D. Guo, Y. Xiang, M. Tian, Y. Zhang, H. Wu, Y. Wei, G. Ma, and Z. Han. 2019. Grape seed proanthocyanidins inhibit proliferation of pancreatic cancer cells by modulating microRNA expression. Oncology Letters 17 (3): 2777–2787.PubMedPubMedCentral Wang, W., L. Zhan, D. Guo, Y. Xiang, M. Tian, Y. Zhang, H. Wu, Y. Wei, G. Ma, and Z. Han. 2019. Grape seed proanthocyanidins inhibit proliferation of pancreatic cancer cells by modulating microRNA expression. Oncology Letters 17 (3): 2777–2787.PubMedPubMedCentral
20.
go back to reference Yang, L., D. Xian, X. Xiong, R. Lai, J. Song, and J. Zhong. 2018. Proanthocyanidins against oxidative stress: from molecular mechanisms to clinical applications. BioMed Research International 2018: 8584136.PubMedPubMedCentral Yang, L., D. Xian, X. Xiong, R. Lai, J. Song, and J. Zhong. 2018. Proanthocyanidins against oxidative stress: from molecular mechanisms to clinical applications. BioMed Research International 2018: 8584136.PubMedPubMedCentral
21.
go back to reference Govindaraj, J., P. Emmadi, V. Deepalakshmi, G. Prakash Rajaram, and R. Puvanakrishnan. 2010. Protective effect of proanthocyanidins on endotoxin induced experimental periodontitis in rats. Indian Journal of Experimental Biology 48 (2): 133–142.PubMed Govindaraj, J., P. Emmadi, V. Deepalakshmi, G. Prakash Rajaram, and R. Puvanakrishnan. 2010. Protective effect of proanthocyanidins on endotoxin induced experimental periodontitis in rats. Indian Journal of Experimental Biology 48 (2): 133–142.PubMed
22.
go back to reference La, V.D., C. Bergeron, S. Gafner, and D. Grenier. 2009. Grape seed extract suppresses lipopolysaccharide-induced matrix metalloproteinase (MMP) secretion by macrophages and inhibits human MMP-1 and-9 activities. Journal of Periodontology 80 (11): 1875–1882.CrossRef La, V.D., C. Bergeron, S. Gafner, and D. Grenier. 2009. Grape seed extract suppresses lipopolysaccharide-induced matrix metalloproteinase (MMP) secretion by macrophages and inhibits human MMP-1 and-9 activities. Journal of Periodontology 80 (11): 1875–1882.CrossRef
23.
go back to reference Toker, H., H. Balci Yuce, A. Lektemur Alpan, F. Gevrek, and M. Elmastas. 2018. Morphometric and histopathological evaluation of the effect of grape seed proanthocyanidin on alveolar bone loss in experimental diabetes and periodontitis. Journal of Periodontal Research 53 (3): 478–486.CrossRef Toker, H., H. Balci Yuce, A. Lektemur Alpan, F. Gevrek, and M. Elmastas. 2018. Morphometric and histopathological evaluation of the effect of grape seed proanthocyanidin on alveolar bone loss in experimental diabetes and periodontitis. Journal of Periodontal Research 53 (3): 478–486.CrossRef
24.
go back to reference Li, M., R. Li, Q. Jin, J. Pang, and Z. Xu. 2017. The efficacy of proanthocyanidins and secnidazole in the treatment of chronic periodontitis after scaling and root planing therapy. Journal of Biological Regulators and Homeostatic Agents 31 (1): 93–97.PubMed Li, M., R. Li, Q. Jin, J. Pang, and Z. Xu. 2017. The efficacy of proanthocyanidins and secnidazole in the treatment of chronic periodontitis after scaling and root planing therapy. Journal of Biological Regulators and Homeostatic Agents 31 (1): 93–97.PubMed
25.
go back to reference Hienz, S.A., S. Paliwal, and S. Ivanovski. 2015. Mechanisms of bone resorption in periodontitis. Journal of Immunology Research. Hienz, S.A., S. Paliwal, and S. Ivanovski. 2015. Mechanisms of bone resorption in periodontitis. Journal of Immunology Research.
26.
go back to reference Mostafa, N.Z., H. Uludag, M. Varkey, D.N. Dederich, M.R. Doschak, and T.H. El-Bialy. 2011. In vitro osteogenic induction of human gingival fibroblasts for bone regeneration. The Open Dentistry Journal 5: 139–145.CrossRef Mostafa, N.Z., H. Uludag, M. Varkey, D.N. Dederich, M.R. Doschak, and T.H. El-Bialy. 2011. In vitro osteogenic induction of human gingival fibroblasts for bone regeneration. The Open Dentistry Journal 5: 139–145.CrossRef
27.
go back to reference Shen, Y.Q., Z.Y. Feng, C.T. Lin, X. Hou, X.J. Wang, J. Wang, Y.L. Yu, L.Y. Wang, and X.H. Sun. 2012. An oligodeoxynucleotide that induces differentiation of bone marrow mesenchymal stem cells to osteoblasts in vitro and reduces alveolar bone loss in rats with periodontitis. International Journal of Molecular Sciences 13 (3): 2877–2892.CrossRef Shen, Y.Q., Z.Y. Feng, C.T. Lin, X. Hou, X.J. Wang, J. Wang, Y.L. Yu, L.Y. Wang, and X.H. Sun. 2012. An oligodeoxynucleotide that induces differentiation of bone marrow mesenchymal stem cells to osteoblasts in vitro and reduces alveolar bone loss in rats with periodontitis. International Journal of Molecular Sciences 13 (3): 2877–2892.CrossRef
28.
go back to reference Xu, X.Y., X. Li, J. Wang, X.T. He, H.H. Sun, and F.M. Chen. 2019. Concise review: periodontal tissue regeneration using stem cells: strategies and translational considerations. Stem Cells Translational Medicine 8 (4): 392–403.CrossRef Xu, X.Y., X. Li, J. Wang, X.T. He, H.H. Sun, and F.M. Chen. 2019. Concise review: periodontal tissue regeneration using stem cells: strategies and translational considerations. Stem Cells Translational Medicine 8 (4): 392–403.CrossRef
29.
go back to reference Weaver, C.M., D.L. Alekel, W.E. Ward, and M.J. Ronis. 2012. Flavonoid intake and bone health. J Nutr Gerontol Geriatr 31 (3): 239–253.CrossRef Weaver, C.M., D.L. Alekel, W.E. Ward, and M.J. Ronis. 2012. Flavonoid intake and bone health. J Nutr Gerontol Geriatr 31 (3): 239–253.CrossRef
30.
go back to reference Zhu, W., Z.Q. Yin, Q. Zhang, S.F. Guo, Y. Shen, T. Liu, B. Liu, et al. 2019. Proanthocyanidins inhibit osteoclast formation and function by inhibiting the NF-kappa B and JNK signaling pathways during osteoporosis treatment. Biochemical and Biophysical Research Communications 509 (1): 294–300.CrossRef Zhu, W., Z.Q. Yin, Q. Zhang, S.F. Guo, Y. Shen, T. Liu, B. Liu, et al. 2019. Proanthocyanidins inhibit osteoclast formation and function by inhibiting the NF-kappa B and JNK signaling pathways during osteoporosis treatment. Biochemical and Biophysical Research Communications 509 (1): 294–300.CrossRef
31.
go back to reference Abreu, R.D., L.O. Penalva, E.M. Marcotte, and C. Vogel. 2009. Global signatures of protein and mRNA expression levels. Molecular BioSystems 5 (12): 1512–1526.PubMedCentral Abreu, R.D., L.O. Penalva, E.M. Marcotte, and C. Vogel. 2009. Global signatures of protein and mRNA expression levels. Molecular BioSystems 5 (12): 1512–1526.PubMedCentral
32.
go back to reference Gorska, R., H. Gregorek, J. Kowalski, A. Laskus-Perendyk, M. Syczewska, and K. Madalinski. 2003. Relationship between clinical parameters and cytokine profiles in inflamed gingival tissue and serum samples from patients with chronic periodontitis. Journal of Clinical Periodontology 30 (12): 1046–1052.CrossRef Gorska, R., H. Gregorek, J. Kowalski, A. Laskus-Perendyk, M. Syczewska, and K. Madalinski. 2003. Relationship between clinical parameters and cytokine profiles in inflamed gingival tissue and serum samples from patients with chronic periodontitis. Journal of Clinical Periodontology 30 (12): 1046–1052.CrossRef
33.
go back to reference Graves, D.T., and D. Cochran. 2003. The contribution of interleukin-1 and tumor necrosis factor to periodontal tissue destruction. Journal of Periodontology 74 (3): 391–401.CrossRef Graves, D.T., and D. Cochran. 2003. The contribution of interleukin-1 and tumor necrosis factor to periodontal tissue destruction. Journal of Periodontology 74 (3): 391–401.CrossRef
34.
go back to reference Algate, K., D.R. Haynes, P.M. Bartold, T.N. Crotti, and M.D. Cantley. 2016. The effects of tumour necrosis factor-alpha on bone cells involved in periodontal alveolar bone loss; osteoclasts, osteoblasts and osteocytes. Journal of Periodontal Research 51 (5): 549–566.CrossRef Algate, K., D.R. Haynes, P.M. Bartold, T.N. Crotti, and M.D. Cantley. 2016. The effects of tumour necrosis factor-alpha on bone cells involved in periodontal alveolar bone loss; osteoclasts, osteoblasts and osteocytes. Journal of Periodontal Research 51 (5): 549–566.CrossRef
35.
go back to reference Gentile, C., M. Allegra, F. Angileri, A.M. Pintaudi, M.A. Livrea, and L. Tesoriere. 2012. Polymeric proanthocyanidins from Sicilian pistachio (Pistacia vera L.) nut extract inhibit lipopolysaccharide-induced inflammatory response in RAW 264.7 cells. European Journal of Nutrition 51 (3): 353–363.CrossRef Gentile, C., M. Allegra, F. Angileri, A.M. Pintaudi, M.A. Livrea, and L. Tesoriere. 2012. Polymeric proanthocyanidins from Sicilian pistachio (Pistacia vera L.) nut extract inhibit lipopolysaccharide-induced inflammatory response in RAW 264.7 cells. European Journal of Nutrition 51 (3): 353–363.CrossRef
36.
go back to reference Abbas, S., Y.H. Zhang, J.C. Clohisy, and Y. Abu-Amer. 2003. Tumor necrosis factor-alpha inhibits pre-osteoblast differentiation through its type-1 receptor. Cytokine 22 (1–2): 33–41.CrossRef Abbas, S., Y.H. Zhang, J.C. Clohisy, and Y. Abu-Amer. 2003. Tumor necrosis factor-alpha inhibits pre-osteoblast differentiation through its type-1 receptor. Cytokine 22 (1–2): 33–41.CrossRef
37.
go back to reference Wang, L.M., N. Zhao, J. Zhang, Q.F. Sun, C.Z. Yang, and P.S. Yang. 2018. Tumor necrosis factor-alpha inhibits osteogenic differentiation of pre-osteoblasts by downregulation of EphB4 signaling via activated nuclear factor-kappaB signaling pathway. Journal of Periodontal Research 53 (1): 66–72.CrossRef Wang, L.M., N. Zhao, J. Zhang, Q.F. Sun, C.Z. Yang, and P.S. Yang. 2018. Tumor necrosis factor-alpha inhibits osteogenic differentiation of pre-osteoblasts by downregulation of EphB4 signaling via activated nuclear factor-kappaB signaling pathway. Journal of Periodontal Research 53 (1): 66–72.CrossRef
38.
go back to reference Cheng, X., M. Kinosaki, R. Murali, and M.I. Greene. 2003. The TNF receptor superfamily - role in immune inflammation and bone formation. Immunologic Research 27 (2–3): 287–294.CrossRef Cheng, X., M. Kinosaki, R. Murali, and M.I. Greene. 2003. The TNF receptor superfamily - role in immune inflammation and bone formation. Immunologic Research 27 (2–3): 287–294.CrossRef
Metadata
Title
Proanthocyanidins Promote Osteogenic Differentiation of Human Periodontal Ligament Fibroblasts in Inflammatory Environment Via Suppressing NF-κB Signal Pathway
Authors
Jiahui Huang
Lianlian Liu
Shanshan Jin
Yu Zhang
Liguo Zhang
Shutong Li
Aimei Song
Pishan Yang
Publication date
01-06-2020
Publisher
Springer US
Published in
Inflammation / Issue 3/2020
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-019-01175-y

Other articles of this Issue 3/2020

Inflammation 3/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.